Virus Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Flu Vaccines
Iomai Announces Year-End 2006 Financial Results and Business Progress
April 10th, 2007
Iomai Corporation (NASDAQ:IOMI) reported financial results and corporate progress for the full year and fourth quarter ended Dec. 31, 2006. "We moved all five of our innovative, patch-based vaccine and immunostimulant programs forward in 2006 and demonstrated the promise of our core technology, transcutaneous immunization (TCI), for improving vaccination for influenza and travelers' diarrhea. This year, we developed initial data showing that the Iomai patches are stable at room temperature and can be mailed or stockpiled, we began a key head-to-head trial of our seasonal influenza vaccine versus the traditional injected vaccine, and we collected important clinical data...
Source: Virus Weekly (2007-04-10)
|
